• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 X 射线诱导的催化反应的 Au-BiS 纳米粒子肖特基型异质结构增强非氧依赖型自由基的生成及其放射增敏作用。

Enhanced Generation of Non-Oxygen Dependent Free Radicals by Schottky-type Heterostructures of Au-BiS Nanoparticles via X-ray-Induced Catalytic Reaction for Radiosensitization.

机构信息

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety , Institute of High Energy Physics, Chinese Academy of Sciences , Beijing 100049 , China.

College of Materials Science and Optoelectronic Technology , University of Chinese Academy of Sciences , Beijing 100049 , China.

出版信息

ACS Nano. 2019 May 28;13(5):5947-5958. doi: 10.1021/acsnano.9b01818. Epub 2019 Apr 15.

DOI:10.1021/acsnano.9b01818
PMID:30969747
Abstract

Despite the development of nanomaterials with high-Z elements for radiosensitizers, most of them suffer from their oxygen-dependent behavior in hypoxic tumor, nonideal selectivity to tumor, or inevasible damages to normal tissue, greatly limiting their further applications. Herein, we develop a Schottky-type heterostructure of Au-BiS with promising ability of reactive free radicals generation under X-ray irradiation for selectively enhancing radiotherapeutic efficacy by catalyzing intracellular HO in tumor. On the one hand, like many other nanomaterials with rich high-Z elements, Au-BiS can deposit higher radiation dose within tumors in the form of high energy electrons. On the other hand, Au-BiS can remarkably improve the utilization of a large number of X-ray-induced low energy electrons during radiotherapy for nonoxygen dependent free radicals generation even in hypoxic condition. This feature of Schottky-type heterostructures Au-BiS attributes to the generated Schottky barrier between metal Au and semiconductor BiS, which can trap the X-ray-generated electrons and transfer them to Au, resulting in efficient separation of the electron-hole pairs. Then, because of the matched potential between the conduction band of BiS and overexpressed HO within tumor, the Au-BiS HNSCs can decompose the intracellular HO into highly toxic OH for selective radiosensitization in tumor. As a consequence, this kind of nanoparticle provides an idea to develop rational designed Schottky-type heterostructures as efficient radiosensitizers for enhanced radiotherapy of cancer.

摘要

尽管已经开发出了具有高 Z 元素的纳米材料作为放射增敏剂,但它们大多数都存在氧依赖性行为、非理想的肿瘤选择性或不可避免的正常组织损伤,这极大地限制了它们的进一步应用。在此,我们开发了一种 Au-BiS 的肖特基型异质结构,具有在 X 射线照射下生成反应性自由基的能力,可通过催化肿瘤内的 HO 来选择性地增强放射治疗效果。一方面,像许多其他富含高 Z 元素的纳米材料一样,Au-BiS 可以以高能电子的形式在肿瘤内沉积更高的辐射剂量。另一方面,Au-BiS 可以显著提高放疗过程中大量 X 射线诱导的低能电子的利用效率,从而即使在缺氧条件下也能生成非氧依赖的自由基。Au-BiS 肖特基型异质结构的这一特性归因于金属 Au 和半导体 BiS 之间产生的肖特基势垒,它可以捕获 X 射线产生的电子,并将其转移到 Au 上,从而实现电子-空穴对的有效分离。然后,由于 BiS 的导带和肿瘤内过表达的 HO 之间的匹配电位,Au-BiS HNSCs 可以将细胞内的 HO 分解为高毒性的 OH,从而实现肿瘤的选择性放射增敏。因此,这种纳米颗粒为开发合理设计的肖特基型异质结构作为增强癌症放射治疗的高效放射增敏剂提供了一种思路。

相似文献

1
Enhanced Generation of Non-Oxygen Dependent Free Radicals by Schottky-type Heterostructures of Au-BiS Nanoparticles via X-ray-Induced Catalytic Reaction for Radiosensitization.基于 X 射线诱导的催化反应的 Au-BiS 纳米粒子肖特基型异质结构增强非氧依赖型自由基的生成及其放射增敏作用。
ACS Nano. 2019 May 28;13(5):5947-5958. doi: 10.1021/acsnano.9b01818. Epub 2019 Apr 15.
2
Near-infrared-II-activatable sulfur-deficient plasmonic BiS-Au heterostructures for photoacoustic imaging-guided ultrasound enhanced high performance phototherapy.近红外二区激活的硫缺陷等离子体 BiS-Au 杂化结构用于光声成像引导的超声增强高效光热治疗。
J Colloid Interface Sci. 2023 Aug 15;644:437-453. doi: 10.1016/j.jcis.2023.04.108. Epub 2023 Apr 25.
3
BiS/TiC-TPP nano-heterostructures induced by near-infrared for photodynamic therapy combined with photothermal therapy on hypoxic tumors.基于近红外光的 BiS/TiC-TPP 纳米杂化结构用于乏氧肿瘤的光动力学治疗与光热治疗联合
J Nanobiotechnology. 2024 Mar 20;22(1):123. doi: 10.1186/s12951-024-02391-x.
4
Synthesis of BiS-Au Dumbbell Heteronanostructures with Enhanced Photocatalytic and Photoresponse Properties.铋-金哑铃型杂化纳米结构的合成及其增强的光催化和光电响应性能。
Langmuir. 2016 Nov 8;32(44):11639-11645. doi: 10.1021/acs.langmuir.6b03213. Epub 2016 Oct 24.
5
Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer.磁铁矿和硫化铋 Janus 异质结构作为乳腺癌体内增强放射治疗的增敏剂。
Biomater Adv. 2022 Sep;140:213090. doi: 10.1016/j.bioadv.2022.213090. Epub 2022 Aug 22.
6
Complete ablation of tumors using synchronous chemoradiation with bimetallic theranostic nanoparticles.使用双金属诊疗纳米颗粒同步放化疗完全消融肿瘤。
Bioact Mater. 2021 Jun 12;7:74-84. doi: 10.1016/j.bioactmat.2021.05.015. eCollection 2022 Jan.
7
Nanostructure and charge transfer in Bi2S3-TiO2 heterostructures.Bi2S3-TiO2异质结构中的纳米结构与电荷转移
Nanotechnology. 2014 May 30;25(21):215702. doi: 10.1088/0957-4484/25/21/215702. Epub 2014 May 2.
8
Characterization of interfacially electronic structures of gold-magnetite heterostructures using X-ray absorption spectroscopy.利用 X 射线吸收光谱学对金-磁铁矿异质结构的界面电子结构进行表征。
J Colloid Interface Sci. 2014 Mar 1;417:325-32. doi: 10.1016/j.jcis.2013.11.069. Epub 2013 Dec 3.
9
Tumor Microenvironment-Responsive Cu(OH)PO Nanocrystals for Selective and Controllable Radiosentization via the X-ray-Triggered Fenton-like Reaction.肿瘤微环境响应型 Cu(OH)PO 纳米晶通过 X 射线触发的类 Fenton 反应实现选择性和可控性放射增敏。
Nano Lett. 2019 Mar 13;19(3):1749-1757. doi: 10.1021/acs.nanolett.8b04763. Epub 2019 Feb 20.
10
Sacrificial-template-free synthesis of core-shell C@BiS heterostructures for efficient supercapacitor and H production applications.用于高效超级电容器和制氢应用的核壳C@BiS异质结构的无牺牲模板合成
Sci Rep. 2018 Mar 8;8(1):4194. doi: 10.1038/s41598-018-22622-0.

引用本文的文献

1
Hybrid biomaterials-based radiosensitizers: Preparations and their applications in enhancing tumor radiotherapy.基于混合生物材料的放射增敏剂:制备方法及其在增强肿瘤放射治疗中的应用。
Mater Today Bio. 2025 Aug 9;34:102186. doi: 10.1016/j.mtbio.2025.102186. eCollection 2025 Oct.
2
Convertible ROS Nanocatalyst/Eliminator for Enhancing Tumor Radio-Immunotherapy and Relieving Radiation Enteritis.用于增强肿瘤放射免疫治疗和缓解放射性肠炎的可转换ROS纳米催化剂/消除剂
Adv Sci (Weinh). 2025 Sep;12(33):e03602. doi: 10.1002/advs.202503602. Epub 2025 Jun 10.
3
Defect-engineered magnetic bismuth nanomedicine for dual-modal imaging and synergistic lung tumor therapy.
用于双模态成像和协同肺癌治疗的缺陷工程化磁性铋纳米药物。
Mater Today Bio. 2025 Mar 18;32:101680. doi: 10.1016/j.mtbio.2025.101680. eCollection 2025 Jun.
4
Bioeliminable Pt@BiSe-RGD Nanoassembly for Enhancing Photoacoustic Imaging-Guided Tumor Immuno-Radiotherapy by Inducing Apoptosis via the Areg Pathway.用于通过Areg途径诱导细胞凋亡增强光声成像引导的肿瘤免疫放疗的可生物消除的Pt@BiSe-RGD纳米组装体
Theranostics. 2025 Jan 27;15(7):2720-2736. doi: 10.7150/thno.106479. eCollection 2025.
5
MXene-based nanosheet for enhanced glioma therapy via photonic hyperthermia to boost the abscopal effect of radioimmunotherapy.基于MXene的纳米片用于通过光子热疗增强胶质瘤治疗,以提高放射免疫疗法的远隔效应。
J Nanobiotechnology. 2025 Mar 11;23(1):203. doi: 10.1186/s12951-025-03288-z.
6
Heterojunction semiconductor nanocatalysts as cancer theranostics.异质结半导体纳米催化剂用于癌症诊疗
APL Bioeng. 2024 Oct 4;8(4):041502. doi: 10.1063/5.0223718. eCollection 2024 Dec.
7
Solid-state electron-mediated z-scheme heterostructured semiconductor nanomaterials induce dual programmed cell death for melanoma therapy.固态电子介导的 Z 型异质结构半导体纳米材料诱导黑色素瘤的双重程序性细胞死亡。
J Nanobiotechnology. 2024 Aug 31;22(1):526. doi: 10.1186/s12951-024-02770-4.
8
A review of recent advances in the use of complex metal nanostructures for biomedical applications from diagnosis to treatment.复杂金属纳米结构在生物医学应用中从诊断到治疗的最新进展综述。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 May-Jun;16(3):e1959. doi: 10.1002/wnan.1959.
9
Application of Multifunctional Nanozymes in Tumor Therapy.多功能纳米酶在肿瘤治疗中的应用。
ACS Omega. 2024 Mar 26;9(14):15753-15767. doi: 10.1021/acsomega.4c00258. eCollection 2024 Apr 9.
10
Recent advances in photothermal nanomaterials-mediated detection of circulating tumor cells.光热纳米材料介导的循环肿瘤细胞检测的最新进展
RSC Adv. 2024 Apr 3;14(15):10672-10686. doi: 10.1039/d4ra00548a. eCollection 2024 Mar 26.